Clinical Trial Materials

October 12th 2023

The 65,000-square-foot facility is designed with the capacity and capability to help scale the next generation of CGTs for human trials and beyond.

June 20th 2023

The new facility also provides a plan for scalable product production processes that can potentially be replicated by Vaxxas domestically and globally.

June 15th 2023

The integration of the binders into a routine lateral flow test will support the clinical and commercial development of rapid diagnostics for Alzheimer’s disease through nasal sampling.

May 2nd 2023

Digital transformation to the Pharma 4.0 paradigm moves forward in process development and clinical and commercial manufacturing.